Oxford Nanopore Technologies PLC
LSE:ONT

Watchlist Manager
Oxford Nanopore Technologies PLC Logo
Oxford Nanopore Technologies PLC
LSE:ONT
Watchlist
Price: 128.8 GBX 4.89% Market Closed
Market Cap: 1.2B GBX
Have any thoughts about
Oxford Nanopore Technologies PLC?
Write Note

Oxford Nanopore Technologies PLC
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oxford Nanopore Technologies PLC
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Oxford Nanopore Technologies PLC
LSE:ONT
Net Issuance of Common Stock
ÂŁ71.6m
CAGR 3-Years
-24%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Net Issuance of Common Stock
-ÂŁ49k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Net Issuance of Common Stock
ÂŁ305k
CAGR 3-Years
-46%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Net Issuance of Common Stock
ÂŁ6k
CAGR 3-Years
-93%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Net Issuance of Common Stock
ÂŁ91k
CAGR 3-Years
-60%
CAGR 5-Years
-58%
CAGR 10-Years
-21%
No Stocks Found

Oxford Nanopore Technologies PLC
Glance View

Market Cap
1.1B GBX
Industry
Life Sciences Tools & Services

Oxford Nanopore Technologies Plc develops proprietary technology platform for the electronic analysis of single molecules. The firm develops sensing technology that uses nanopores - nano-scale holes embedded in electronics, to perform molecular analyses. Its products sequence deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Its product includes a sensing platform, which is used for the analysis of various types of molecules, such as proteins. The firm's platform is used by scientific researchers to answer questions about the biology of people, plants, animals, pathogens and environments. The company is also used in applied settings, such as clinical diagnostics, epidemiology and food safety. Its areas of research include microbiology, microbiome, environmental, plant, animal, infectious disease, human genomics, clinical research, cancer, transcriptome and populations genomics. The firm's other products include MinION, GridION, PromethION, VolTRAX, Flongle Flow Cells, PromethION Flow Cells, and MinION and Gridion Flow Cells.

ONT Intrinsic Value
181.2 GBX
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Oxford Nanopore Technologies PLC's Net Issuance of Common Stock?
Net Issuance of Common Stock
71.6m GBP

Based on the financial report for Dec 31, 2023, Oxford Nanopore Technologies PLC's Net Issuance of Common Stock amounts to 71.6m GBP.

What is Oxford Nanopore Technologies PLC's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-7%

Over the last year, the Net Issuance of Common Stock growth was 1 809%. The average annual Net Issuance of Common Stock growth rates for Oxford Nanopore Technologies PLC have been -24% over the past three years , -7% over the past five years .

Back to Top